Coral Laboratories Share Price

Small Cap | Pharmaceuticals and health care | BSE: 524506

₹757.60 image20.05 (2.72 %)

Last Updated: 13 Mar 2025 12:00 AM

Technicalsimage BEARISHimage

Overview

Open (₹) 731.10

High (₹) 769.00

Low (₹) 730.00

Prev. Close (₹) 737.55

Volume 719

VWAP (₹) 729.72

ROCE (%) 11.55

Industry P/E 43.95

TTM P/E 9.98

P/B Ratio 1.52

Market Cap (₹) Cr.270.66

Dividend Yield (%)0.26

EPS (₹) 44.19

ROE8.89%

Sales Growth (%) 7.09

Profit Growth (%)144.97

Day Range

769.00769.00

L
H

52 Week Range

355.00999.00

L
H

Historical Returns

Returns (6M)

-19.92 %

Returns (1Y)

83.02 %

Returns (3Y)

176.45 %

Returns (5Y)

480.31 %

Returns (6M)

-19.92 %

Returns (1Y)

83.02 %

Returns (3Y)

176.45 %

Returns (5Y)

480.31 %

SWOT Analysis

  • Growth in Net Profit Margin (QoQ)
  • Strong long-term momentum: Price above long-term moving averages (EMA_200)
  • Price above the pivot point indicates bullish sentiment.

Technicals
info_icon

Technical Rating

Trendimage  BEARISH
Moving Averages
Technical Indicators
Bullish
Bullish

RSI 64.77

MFI 69.29

ATR 41.02

Commodity Channel Index -131.53

ROC125 -20.81

ROC21 -1.69

Williams %R -73.81

Resistance & Support
info_icon

TypeResistance 1 Resistance 2 Resistance 3 PP Support 1 Support 2 Support 3
Current758.11778.93801.96735.08714.26691.23670.41
Week Ago787.34794.97799.64782.67775.04770.37762.74
Month Ago767.90783.95807.90743.95727.90703.95687.90

EMA & SMA
info_icon

757.60

Current Price

EMA & SMApin

Bullish Moving Averages

2

Bearish Moving Averages

18

5 Day 775.33


9 Day 781.88


10 Day 786.91


12 Day 766.00


14 Day 769.40

20 Day 770.42


26 Day 766.22


50 Day 771.34


100 Day 797.69


200 Day 753.47

Deals & Announcements

Bulk and Block Deals

Client NameDeal TypeActionDateAvg. PriceQuantityExchange
NEELAM MITTALbulkSell24 May, 2024₹539.621,100BSE
NEELAM MITTALbulkBuy24 May, 2024₹537.8221,709BSE
VAIBHAV RAJENDRA DOSHIbulkSell08 Sept, 2022₹276.4819,050BSE
GUTTIKONDA VARA LAKSHMIbulkSell13 Dec, 2021₹286.8920,000BSE
GUTTIKONDA VARA LAKSHMIbulkBuy20 Apr, 2020₹164.9520,000BSE

Insider Trading

DateNameActionAvg. PriceQuantityDeal Value
22 Feb, 2022CHETAN NAVINCHANDRA DOSHIDisposalBSE

Corporate Actions

Announcement DateSubjectEx - DateRecord Date
13 Jul, 2024Rs.2.0000 per share(20%)Final Dividend20 Sept, 202401 Jan, 1970

Announcements

DateSourceDetail
13 Feb, 2025BSE IndiaIn accordance with amendments to the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 (Third Amendment) Regulations, 2024 read with SEBI Circular No. SEBI/HO/CFD/CFD-PoD-2/CIR/P/2024/185 dated 31st December, 2024, read with BSE Circular No. 20250102-4 the Integrated Filing (Financial) for the quarter and nine months ended 31st December, 2024 is enclosed.
13 Feb, 2025BSE IndiaTo consider and adopt the Unaudited Standalone Financial Results for the quarter and nine months ended December 31 2024, with the Limited Review Report
13 Feb, 2025BSE IndiaTo consider and adopt the Unaudited Standalone Financial Results for the quarter and nine months ended December 31 2024, with the Limited Review Report in terms of Regulation 33 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015
05 Feb, 2025BSE IndiaCORAL LABORATORIES LTD.has informed BSE that the meeting of the Board of Directors of the Company is scheduled on 13/02/2025 ,inter alia, to consider and approve Financial Results Of The Company For The Quarter And Nine Months Ended December 31, 2024
03 Jan, 2025BSE IndiaChange Of Name Of Registrar And Share Transfer Agent Of The Company
19 Dec, 2024BSE IndiaDear Sir/ Madam,\r\n\r\nPursuant to Regulation 30 of SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015\r\n('SEBI (LODR) Regulations') this is to inform you that BSE Ltd. Vide email dated December 13, 2024, imposed penalty of Rs. 45,000/- (Rupees Fourty Five Thousand only) for delay in submission of Limited Review Report which is part of Financial Result which was missed inadvertently. \r\n\r\nKindly acknowledge receipt and record the same\r\n
26 Nov, 2024BSE IndiaSubmission of Limited Review Report missed inadvertently in financial result submitted on 14th November, 2024\r\n
14 Nov, 2024BSE IndiaDear Sir/Madam,\r\n\r\nSub: Disclosure under Reg 23(9) of SEBI (LODR) Regulations, 2015\r\n\r\nPursuant to Regulation 23(9) of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we hereby submit disclosure of Related Party Transactions for the half year ended September 30, 2024, in accordance with the applicable Accounting Standards.\r\n\r\nThis is for your information and record.\r\n
14 Nov, 2024BSE India\r\nPursuant Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015, we enclosed herewith following: \r\n\r\n1. The Unaudited Standalone Financial Results of the Company for the quarter and half year ended September 30, 2024.\r\n2. Limited Review Report thereon.\r\n3. Statement of Asset & Liabilities for the half year ended September 30,2024.\r\n4. Cash Flow Statements for the half year ended September 30,2024.\r\n
14 Nov, 2024BSE IndiaIn terms of Regulation 33 of the SEBI (Listing Obligations and Disclosure Requirements) Regulations, 2015 and other applicable provisions, the Board of Directors of the Company in its meeting held on Thursday, 14th November 2024 at the Corporate Office of the Company situated at 3B, Patanwala Compound, Opp. Shreyas Cinema, L.B.S. Marg, Ghatkopar (W), Mumbai- 400086 at 2:30 P.M, has inter alia considered and approved: \r\n\r\n1. The Unaudited Standalone Financial Results along with Statement of Asset & Liabilities and Cash Flow Statement for the quarter and half year ended September 30, 2024 and took note of the Limited Review Report submitted by M A Parekh & Associates, Statutory Auditor of the Company.\r\n\r\n\r\n\r\n

Board Meetings

PurposeDetailsMeeting DateBroadcast Date
Quarterly Results--06 Feb, 202513 Feb, 2025
Quarterly Results--07 Nov, 202414 Nov, 2024
Quarterly Results--07 Aug, 202414 Aug, 2024
Others--07 Aug, 202409 Aug, 2024
Others--06 Jul, 202413 Jul, 2024
Audited Results--20 May, 202423 May, 2024
OthersInter alia, to consider and approve the Appointment of Company Secretary.19 Apr, 202424 Apr, 2024
OthersInter alia, 1. To appoint Company Secretary and Compliance Officer of the company.01 Mar, 202408 Mar, 2024
Quarterly Results--08 Feb, 202414 Feb, 2024
Quarterly Results--03 Nov, 202309 Nov, 2023

Share Holding Pattern

Loading...

Loading...

Owner NameDec, 2024Sept, 2024Jun, 2024Mar, 2024Dec, 2023

About Coral Laboratories

Coral Laboratories is a Public Limited Listed company incorporated on 06/02/1997 and has its registered office in the State of Maharashtra, India. Company’s Corporate Identification Number(CIN) is L24231MH1997PLC422233 and registration number is 422233. Currently Company is involved in the business activities of Manufacture of pharmaceuticals, medicinal chemical and botanical products. Company’s Total Operating Revenue is Rs. 83.66 Cr. and Equity Capital is Rs. 3.57 Cr. for the Year ended 31/03/2024. Read More

Parent Organisation

Not Applicable

Founded

1997

Managing Director

-- --

NSE Symbol

--

Coral Laboratories Management

NameDesignation
Mrs. Sushma KadkadeDirector & CFO
Ms. Pooja HindiaIndependent Director
Dr. Saurabh ShahIndependent Director
Mr. Malay DoshiIndependent Director
Mr. Rajendrasinh RanaDirector
Mr. Girish M DhamejaWhole Time Director

Peer Comparison

StocksMarket CapMarket Price52 Week Low-High
Sun Pharmaceutical Industries₹4,03,916.05₹1,683.45 image
₹1,676.85(0.39%)
₹1,376.750 - ₹1,960.200
Divi's Laboratories₹1,49,205.29₹5,620.45 image
₹5,667.15(-0.82%)
₹3,350.050 - ₹6,448.750
Cipla₹1,18,065.23₹1,461.90 image
₹1,454.30(0.52%)
₹1,317.600 - ₹1,702.000
Torrent Pharmaceuticals₹1,03,430.62₹3,056.05 image
₹3,096.50(-1.31%)
₹2,488.000 - ₹3,589.950
Dr. Reddy's Laboratories₹92,453.48₹1,107.95 image
₹1,105.15(0.25%)
₹1,093.000 - ₹1,420.200

FAQs on Coral Laboratories

What is the share price of Coral Laboratories?

The share price of Coral Laboratories on 13 Mar, 2025 is ₹ 757.60.

What is 52W high and 52W low share price of Coral Laboratories?

The highest and lowest 52W share prices of Coral Laboratories are ₹ 999.000 and ₹ 355.000

What is the market cap of Coral Laboratories?

The market capitalization of Coral Laboratories as of 13 Mar, 2025 is ₹ 270.66 Crores

What is the P/E ratio of Coral Laboratories?

The current P/E ratio of Coral Laboratories as of 13 Mar, 2025 is 43.95

What is the PB ratio of Coral Laboratories?

The PB ratio of Coral Laboratories as of 13 Mar, 2025 is 1.52

Top Gainers

₹6.97image

₹5.81 (0.20%)

₹194.70image

₹162.25 (0.20%)

Top Losers

₹13.75image

₹135.15 (-0.90%)

₹9.60image

₹12.00 (-0.20%)

₹9.80image

₹93.55 (-0.90%)

₹0.99image

₹4.77 (-0.79%)

Market Indices

Sensex

₹73,828.91image

₹74,029.76 (0.00%)

Source : Dion Global Solutions Limited